Cargando…

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group B adenovirus EnAdenotucirev (EnAd) to express a bispecific single‐chain antibody, secreted from infected tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freedman, Joshua D, Hagel, Joachim, Scott, Eleanor M, Psallidas, Ioannis, Gupta, Avinash, Spiers, Laura, Miller, Paul, Kanellakis, Nikolaos, Ashfield, Rebecca, Fisher, Kerry D, Duffy, Margaret R, Seymour, Leonard W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538299/ https://www.ncbi.nlm.nih.gov/pubmed/28634161 http://dx.doi.org/10.15252/emmm.201707567

Ejemplares similares

Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization
por: O’Cathail, Sean M., et al.
Publicado: (2017)

Oncolytic viruses: finally delivering
por: Seymour, Leonard W, et al.
Publicado: (2016)

NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
por: Leung, Elaine Y.L., et al.
Publicado: (2020)

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
por: Illingworth, Sam, et al.
Publicado: (2017)

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
por: Lei, Janet, et al.
Publicado: (2018)

Tackling HLA Deficiencies Head on with Oncolytic Viruses
por: Fisher, Kerry, et al.
Publicado: (2021)

Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
por: de Sostoa, Jana, et al.
Publicado: (2019)

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
por: Dyer, Arthur, et al.
Publicado: (2016)

Oncolytic adenovirus coding for bispecific T cell engager against human MUC-1 potentiates T cell response against solid tumors
por: Basnet, Saru, et al.
Publicado: (2022)

Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)

Oncolytic Adenoviruses in Cancer Treatment
por: Alemany, Ramon
Publicado: (2014)

Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020)

Oncolytic Adenoviruses for Cancer Therapy
por: Tripodi, Lorella, et al.
Publicado: (2021)

Concepts in Oncolytic Adenovirus Therapy
por: Mantwill, Klaus, et al.
Publicado: (2021)

A Renaissance for Oncolytic Adenoviruses?
por: Blanchette, Paola, et al.
Publicado: (2023)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Designer Oncolytic Adenovirus: Coming of Age
por: Baker, Alexander T., et al.
Publicado: (2018)

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021)

Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022)

Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023)

"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
por: Champion, Brian R, et al.
Publicado: (2014)

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins
por: Bachtarzi, Houria, et al.
Publicado: (2011)

Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinoma
por: Yuan, Xiangfei, et al.
Publicado: (2023)

Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer
por: Freytag, Svend O, et al.
Publicado: (2015)

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2015)

A novel oncolytic adenovirus based on simian adenovirus serotype 24
por: Cheng, Tao, et al.
Publicado: (2017)

Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)

Oncolytic adenovirus-mediated therapy for prostate cancer
por: Sweeney, Katrina, et al.
Publicado: (2016)

Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
por: Hajeri, Praveensingh B., et al.
Publicado: (2020)

Photoactivatable oncolytic adenovirus for optogenetic cancer therapy
por: Hagihara, Yasuko, et al.
Publicado: (2020)

Species D Adenoviruses as Oncolytic Viral Vectors
por: Bullard, Brianna L., et al.
Publicado: (2020)

Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
por: Hensen, Lobke C.M., et al.
Publicado: (2020)

Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2020)

RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells
por: Yang, Y, et al.
Publicado: (2015)

Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion
por: Yousaf, Iris, et al.
Publicado: (2020)

Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
por: Heidbuechel, Johannes P. W., et al.
Publicado: (2021)

Oncolytic adenoviruses: A potent form of tumor immunovirotherapy
por: Cerullo, Vincenzo, et al.
Publicado: (2012)

Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
por: Vera, Beatriz, et al.
Publicado: (2016)

Oncolytic Replication of E1b-Deleted Adenoviruses
por: Cheng, Pei-Hsin, et al.
Publicado: (2015)

Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors
por: Gibson, Heather, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f83b3gi171ts7p2dt27jjn5jr6